Basic Search  |  Summaries  |  Advanced SearchPenalty: £23,000,000
Year: 2024
Date: 10 December, 2024
Offence Group: competition-related offences
Offence Type: price-fixing or anti-competitive practices
Violation Description: Vifor Pharma addressed the CMA's investigation, into whether the company had restricted competition by spreading misinformation to healthcare professionals about the safety of a rival treatment, by offering a number of commitments to the CMA including a £23 million payment to healthcare systems.
Settlement Type: Settlement with CMA
Agency: Competition and Markets Authority
HQ Country of Parent: Australia
Ownership Structure of Parent: publicly traded
Major Industry of Parent: pharmaceuticals
Specific Industry of Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: The offer was announced by the CMA for consultation until 17th January 2025. Awaiting information on the final agreement.